View Older Stories

Jul 13, 2026 06:41AM Ionis Pharmaceuticals (IONS) PT Lowered to $125 at H.C. Wainwright

Jul 10, 2026 06:53AM Ionis Pharmaceuticals (IONS) PT Lowered to $95 at Canaccord

Jul 10, 2026 06:06AM Ionis Pharmaceuticals (IONS) reaffirms guidance

Jul 10, 2026 05:10AM Ionis Pharmaceuticals (IONS) PT Lowered to $90 at Barclays

Jul 9, 2026 04:01PM Ionis Pharmaceuticals (IONS) PT Lowered to $100 at Citi

Jul 9, 2026 12:50PM Ionis Pharmaceuticals (IONS) PT Lowered to $90 at Jefferies

Jul 9, 2026 12:40PM Ionis Pharmaceuticals (IONS) PT Lowered to $86 at Needham

Jul 9, 2026 11:54AM Ionis Pharmaceuticals (IONS) PT Lowered to $90 at BofA Securities

Jul 9, 2026 11:53AM Ionis Pharmaceuticals (IONS) PT Lowered to $94 at TD Cowen

Jul 9, 2026 09:42AM Ionis Pharmaceuticals (IONS) PT Lowered to $92 at Oppenheimer

Jul 9, 2026 06:16AM Stifel: 'We expect IONS shares to trade lower today and ALNY shares to be volatile'

Jun 25, 2026 07:12AM Needham Reiterates Buy Rating on Ionis Pharmaceuticals (IONS)

Jun 25, 2026 06:48AM Ionis Pharmaceuticals (IONS) PT Raised to $130 at H.C. Wainwright

Jun 25, 2026 03:33AM Oppenheimer Reiterates Outperform Rating on Ionis Pharmaceuticals (IONS)

Jun 24, 2026 02:39PM FDA approves Ionis drug Tryngolza for severe hypertriglyceridemia

Jun 1, 2026 06:57AM H.C. Wainwright Reiterates Buy Rating on Ionis Pharmaceuticals (IONS)

May 27, 2026 06:44AM H.C. Wainwright Reiterates Buy Rating on Ionis Pharmaceuticals (IONS)

May 26, 2026 05:33AM Wolfe: 'Arrowhead Q3 data in acute pancreatitis will be the next big event to readthrough to Ionis. We see 74% odds of IONS stock down, 26% odds up'

Apr 30, 2026 08:39AM Ionis Pharmaceuticals (IONS) PT Raised to $100 at RBC Capital

Apr 30, 2026 07:36AM Ionis Pharmaceuticals (IONS) PT Raised to $96 at Bernstein SocGen Group

Apr 29, 2026 05:40PM Ionis Pharmaceuticals (IONS) PT Raised to $110 at Oppenheimer

Apr 29, 2026 04:10PM Ionis Pharmaceuticals (IONS) PT Raised to $86 at Stifel

Apr 29, 2026 07:10AM Ionis Pharmaceuticals (IONS) Tops Q1 EPS by 29c ; Offers Guidance

Apr 26, 2026 08:00PM U.S. Biotech stocks: Q1 earnings previews

Apr 21, 2026 07:03AM Ionis reports positive zilganersen data for Alexander disease

Apr 9, 2026 04:28PM Raymond James Starts Ionis Pharmaceuticals (IONS) at Outperform, 'Taking Returns to Heart (and Mind)'

Mar 31, 2026 06:41AM H.C. Wainwright Reiterates Buy Rating on Ionis Pharmaceuticals (IONS)

Mar 25, 2026 05:45PM William Blair stays Outperform on Ionis Pharmaceuticals (IONS); pricing update 'positive'

Mar 25, 2026 03:58PM Ionis Pharmaceuticals (IONS) PT Raised to $106 at Barclays

Mar 25, 2026 03:42PM RBC Capital Reiterates Outperform Rating on Ionis Pharmaceuticals (IONS)

Mar 25, 2026 12:24PM BofA Securities stays Buy on Ionis Pharmaceuticals (IONS) as new pricing 'a positive update'

Mar 25, 2026 11:44AM Ionis Pharmaceuticals (IONS) PT Raised to $83 at Stifel

Mar 25, 2026 10:58AM Ionis Pharmaceuticals (IONS) PT Raised to $120 at H.C. Wainwright

Mar 25, 2026 10:13AM Ionis Pharmaceuticals (IONS) PT Raised to $104 at Oppenheimer

Mar 25, 2026 10:12AM Ionis Pharmaceuticals (IONS) PT Raised to $114 at Leerink Partners

Mar 25, 2026 09:46AM Wolfe Research on Ionis Pharmaceuticals (IONS): new Tryngolza pricing likely to ‘squeeze’ Arrowhead’s rival drug

Mar 6, 2026 10:34AM Ionis Pharmaceuticals (IONS) March 70 and 75 puts as share price down 1%

Mar 5, 2026 01:10PM Ionis Pharmaceuticals (IONS) March 70 and 75 puts active, share price down 4.8%

Feb 27, 2026 07:02AM Ionis to present DAWNZERA data at 2026 AAAAI meeting

Feb 26, 2026 05:53AM Ionis Pharmaceuticals (IONS) PT Raised at Bernstein Ahead of a Catalyst-Rich 2H26

Feb 26, 2026 05:32AM Ionis Pharmaceuticals (IONS) PT Raised to $77 at Stifel

Feb 25, 2026 03:46PM Ionis Pharmaceuticals (IONS) PT Raised to $95 at Morgan Stanley

Feb 25, 2026 01:20PM RBC Capital Reiterates Outperform Rating on Ionis Pharmaceuticals (IONS)

Feb 25, 2026 07:03AM Ionis Pharmaceuticals (IONS) Misses Q4 EPS by 8c, provides guidance

Feb 4, 2026 07:30AM BIOGEN publishes study results for high-dose nusinersen in Nature Medicine

Jan 21, 2026 07:00AM DAWNZERA gets European Commission approval for hereditary angioedema

Jan 12, 2026 11:06AM BIOGEN receives EU approval for high dose SPINRAZA for spinal muscular atrophy

Dec 17, 2025 05:28AM Ionis Pharmaceuticals (IONS) PT Raised to $95 at RBC Capital

Dec 3, 2025 08:26AM TD Cowen on Ionis Pharmaceuticals (IONS): 'New Launches And Key Pipeline Catalysts To Drive Upside'

Nov 17, 2025 06:02AM Biogen (BIIB): High Dose Regimen of Nusinersen Receives Positive CHMP Opinion for the Treatment of Spinal Muscular Atrophy

View Older Stories